Position in URGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,089,832
New position
Shares Held
29,615
first reported quarter
Ownership
0.061%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 190 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026POLEN CAPITAL MANAGEMENT LLC holds $34,878,895 across 19 Biotechnology names. URGN ranks #13 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TWST |
Twist Bioscience Corp
|
55,310 | $5,690,292 | |
| 2 | TSHA |
Taysha Gene Therapies, Inc.
|
489,219 | $3,331,581 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
52,132 | $2,867,260 | |
| 4 | DRTS |
Alpha Tau Medical Ltd.
|
220,751 | $2,777,047 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
22,651 | $2,776,559 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
20,899 | $2,446,645 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
7,252 | $2,427,897 | |
| 8 | AKTS |
Aktis Oncology, Inc.
|
63,514 | $2,047,056 |
All Filings in URGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,089,832 | 29,615 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||